Loading…
Preventing Overdoses and Saving Lives Act 2.0
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Preventing Overdoses and Saving Lives Act 2.0 This bill reauthorizes through FY2027, modifies eligibility for, and otherwise makes changes to grants for increasing access to emergency treatments to reverse opioid overdoses (e.g., naloxone).
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
2023 · third_quarter · Health Issues
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, Further Extending Government Funding Act (PL 117-70); Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act (117th Congress); FY 2024 National Defense Authorization Act - provisions related to biological and chemical defense and access to naloxone; Issues related to H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 (117th Congress); H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 (117th Congress); Issues related to the implementation of PREVENT Pandemics Act in Consolidated Appropriations Act, 2023 (PL 117-328).
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2023 · second_quarter · Health Issues
Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act; FY 2024 National Defense Authorization Act - provisions related to biological and chemical defense and access to naloxone; Issues related to H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 (117th Congress); H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 (117th Congress); Issues related to the implementation of S. 3799 - PREVENT Pandemics Act in H.R. 2617 - Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2023 · first_quarter · Health Issues
Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act; FY 2024 National Defense Authorization Act - provisions related to biological and chemical defense and access to naloxone; Issues related to H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 (117th Congress); H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 (117th Congress); Issues related to the implementation of S. 3799 - PREVENT Pandemics Act in H.R. 2617 - Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2022 · fourth_quarter · Health Issues
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 H.R 2366/S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R. 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Disaster Planning/Emergencies
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 2617 - Consolidated Appropriations Act, 2023 (Omnibus) HR 1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Homeland Security
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 2617 - Consolidated Appropriations Act, 2023 (Omnibus) HR 1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
2022 · fourth_quarter · Budget/Appropriations
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 2617 - Consolidated Appropriations Act, 2023 (Omnibus) HR 1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
2022 · fourth_quarter · Pharmacy
Issues related to overdose reversal products; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659), FY2023 Consolidated Appropriations Act (H.R.2617); H.R.7681, Preventing Overdoses and Saving Lives Act 2.0; H.R.7666, Restoring Hope for Mental Health and Well-Being Act of 2022; H.R.7189, School Resource Officers Save Lives Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Budget/Appropriations
Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $10,000
2022 · fourth_quarter · Disaster Planning/Emergencies
Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $10,000
2022 · fourth_quarter · Health Issues
Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $10,000
2022 · fourth_quarter · Homeland Security
Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $10,000
2022 · fourth_quarter · Budget/Appropriations
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $640,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · fourth_quarter · Disaster Planning/Emergencies
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $640,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · fourth_quarter · Health Issues
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $640,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
2022 · fourth_quarter · Homeland Security
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $640,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · fourth_quarter · Health Issues
Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act; H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone; Issues related to H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0; H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022; S. 3799 - PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $60,000
2022 · third_quarter · Disaster Planning/Emergencies
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 6833 - House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
2022 · third_quarter · Budget/Appropriations
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 6833 - House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
2022 · third_quarter · Homeland Security
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 6833 - House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
2022 · third_quarter · Pharmacy
Issues related to overdose reversal products; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); H.R.7681, Preventing Overdoses and Saving Lives Act 2.0; H.R.7666, Restoring Hope for Mental Health and Well-Being Act of 2022; H.R.7189, School Resource Officers Save Lives Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2022 · third_quarter · Health Issues
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 H.R 2366/S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R. 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act; H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone; Issues related to H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0; H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022; S. 3799 - PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $60,000
2022 · third_quarter · Health Issues
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
2022 · third_quarter · Homeland Security
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · third_quarter · Budget/Appropriations
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · third_quarter · Disaster Planning/Emergencies
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Homeland Security
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
2022 · second_quarter · Budget/Appropriations
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
2022 · second_quarter · Disaster Planning/Emergencies
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
2022 · second_quarter · Disaster Planning/Emergencies
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2022 · second_quarter · Pharmacy
Issues related to overdose reversal products; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; H.R.7681, Preventing Overdoses and Saving Lives Act 2.0; H.R.7666, Restoring Hope for Mental Health and Well-Being Act of 2022; H.R.7189, School Resource Officers Save Lives Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 H.R 2366/S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R. 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - Provisions related to biological and chemical defense and access to Naloxone House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341/S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366/S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $590,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
2022 · second_quarter · Homeland Security
H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - Provisions related to biological and chemical defense and access to Naloxone House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341/S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366/S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $590,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Budget/Appropriations
H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - Provisions related to biological and chemical defense and access to Naloxone House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341/S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366/S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $590,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Disaster Planning/Emergencies
H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - Provisions related to biological and chemical defense and access to Naloxone House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341/S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366/S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $590,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Health Issues
Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act; H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone; Issues related to H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0; H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022; S. 3799 - PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $60,000
| Republican |
| NE |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)